Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
26.72
-0.09 (-0.34%)
At close: Oct 7, 2026, 4:00 PM EDT
26.72
0.00 (0.00%)
Pre-market: Oct 8, 2026, 4:00 AM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $27.18 million as of October 7, 2026. That makes Quince Therapeutics the 34,882nd most valuable company in the world and 5,076th in the United States. Its market cap has decreased by 74.05% in one year.
Market Cap
27.18M
Enterprise Value
-88.81M
1-Year Change
-74.05%
Global Rank
Country Rank
#5,076 United States
Category
ChartMarket Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.57M to $27.18M, a decrease of -96.82%. That is a compound annual growth rate of -37.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 27.18M | -85.43% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 31.84M |
| BeyondSpring | 31.26M |
| Context Therapeutics | 30.97M |
| GridAI Technologies | 29.74M |
| TransCode Therapeutics | 29.71M |
| IGC Pharma | 29.35M |
| aTyr Pharma | 28.77M |
| Seres Therapeutics | 28.33M |